These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 21619515)
21. Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferase. Špaček P; Keough DT; Chavchich M; Dračínský M; Janeba Z; Naesens L; Edstein MD; Guddat LW; Hocková D J Med Chem; 2017 Sep; 60(17):7539-7554. PubMed ID: 28813147 [TBL] [Abstract][Full Text] [Related]
22. Apical membrane antigen 1 as an anti-malarial drug target. Macraild CA; Anders RF; Foley M; Norton RS Curr Top Med Chem; 2011; 11(16):2039-47. PubMed ID: 21619512 [TBL] [Abstract][Full Text] [Related]
23. Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of 6-oxopurine phosphoribosyltransferases and have antimalarial activity. Keough DT; Špaček P; Hocková D; Tichý T; Vrbková S; Slavětínská L; Janeba Z; Naesens L; Edstein MD; Chavchich M; Wang TH; de Jersey J; Guddat LW J Med Chem; 2013 Mar; 56(6):2513-26. PubMed ID: 23448281 [TBL] [Abstract][Full Text] [Related]
24. Purine and pyrimidine pathways as targets in Plasmodium falciparum. Cassera MB; Zhang Y; Hazleton KZ; Schramm VL Curr Top Med Chem; 2011; 11(16):2103-15. PubMed ID: 21619511 [TBL] [Abstract][Full Text] [Related]
25. The effect of novel [3-fluoro-(2-phosphonoethoxy)propyl]purines on the inhibition of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases. Baszczyňski O; Hocková D; Janeba Z; Holý A; Jansa P; Dračínský M; Keough DT; Guddat LW Eur J Med Chem; 2013 Sep; 67():81-9. PubMed ID: 23850568 [TBL] [Abstract][Full Text] [Related]
26. A knowledge-based approach for identification of drugs against vivapain-2 protein of Plasmodium vivax through pharmacophore-based virtual screening with comparative modelling. Yadav MK; Singh A; Swati D Appl Biochem Biotechnol; 2014 Aug; 173(8):2174-88. PubMed ID: 24970047 [TBL] [Abstract][Full Text] [Related]
27. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia. Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226 [TBL] [Abstract][Full Text] [Related]
34. Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum. Naguib FNM; Wilson CM; El Kouni MH Int J Biochem Cell Biol; 2018 Dec; 105():115-122. PubMed ID: 30381242 [TBL] [Abstract][Full Text] [Related]
35. Drug-resistant malaria in children and in travelers. Longworth DL Pediatr Clin North Am; 1995 Jun; 42(3):649-64. PubMed ID: 7761145 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics. Keough DT; Hocková D; Holý A; Naesens LM; Skinner-Adams TS; Jersey Jd; Guddat LW J Med Chem; 2009 Jul; 52(14):4391-9. PubMed ID: 19527031 [TBL] [Abstract][Full Text] [Related]
37. In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound. Bouillon A; Giganti D; Benedet C; Gorgette O; Pêtres S; Crublet E; Girard-Blanc C; Witkowski B; Ménard D; Nilges M; Mercereau-Puijalon O; Stoven V; Barale JC J Biol Chem; 2013 Jun; 288(25):18561-73. PubMed ID: 23653352 [TBL] [Abstract][Full Text] [Related]
38. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia. Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP Malar J; 2006 Jul; 5():54. PubMed ID: 16817953 [TBL] [Abstract][Full Text] [Related]